{"id":"https://openalex.org/W583234580","doi":null,"title":"Anxiety disorders : pathophysiology and pharmacological treatment","display_name":"Anxiety disorders : pathophysiology and pharmacological treatment","alternate_titles":[],"publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W583234580","mag":"583234580"},"language":"en","primary_location":{"id":"mag:583234580","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA61596214","pdf_url":null,"source":{"id":"https://openalex.org/S4306462922","display_name":"Birkh\u00e4user-Verlag eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Birkhauser Verlag eBooks","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W583234580"],"child_works_count":0,"type":"book","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013174263","display_name":"G\u00e9rard Emilien","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"G\u00e9rard Emilien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5013174263"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2458,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.84304933,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pathophysiology","display_name":"pathophysiology","score":0.7829999923706055},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/generalized-anxiety-disorder","display_name":"generalized anxiety disorder","score":0.8899999856948853},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.8059999942779541},{"id":"https://openalex.org/keywords/social-anxiety-disorder","display_name":"social anxiety disorder","score":0.9959999918937683},{"id":"https://openalex.org/keywords/posttraumatic-stress-disorder","display_name":"post-traumatic stress disorder","score":0.9860000014305115},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.9089999794960022},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.8479999899864197},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.9010000228881836},{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":0.8769999742507935},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.6740000247955322},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.8339999914169312},{"id":"https://openalex.org/keywords/gaba-receptors","display_name":"GABA receptors","score":0.6919999718666077},{"id":"https://openalex.org/keywords/serotonin-receptors","display_name":"serotonin receptors","score":0.9459999799728394},{"id":"https://openalex.org/keywords/neuroimaging","display_name":"neuroimaging","score":0.675000011920929},{"id":"https://openalex.org/keywords/genetic-factors","display_name":"genetic factors","score":0.7409999966621399},{"id":"https://openalex.org/keywords/childhood-anxiety","display_name":"childhood anxiety","score":0.35899999737739563}],"concepts":[{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.7630269527435303},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.6368658542633057},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5912563800811768},{"id":"https://openalex.org/C2909738485","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anti-Anxiety Agents","level":3,"score":0.4793891906738281},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.47605225443840027},{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.47315701842308044},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.4648783206939697},{"id":"https://openalex.org/C2777527207","wikidata":"https://www.wikidata.org/wiki/Q2015728","display_name":"Specific phobia","level":4,"score":0.4433676600456238},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.4266108274459839},{"id":"https://openalex.org/C2777545354","wikidata":"https://www.wikidata.org/wiki/Q3557657","display_name":"Social anxiety","level":3,"score":0.4232464134693146},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4139212965965271},{"id":"https://openalex.org/C2776468701","wikidata":"https://www.wikidata.org/wiki/Q412174","display_name":"Pregabalin","level":2,"score":0.41339460015296936},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.41040247678756714},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3227041959762573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2738889455795288},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19649308919906616},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1718454658985138},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.12577062845230103}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:583234580","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA61596214","pdf_url":null,"source":{"id":"https://openalex.org/S4306462922","display_name":"Birkh\u00e4user-Verlag eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Birkhauser Verlag eBooks","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W590373664","https://openalex.org/W588771062","https://openalex.org/W619132242","https://openalex.org/W631149255","https://openalex.org/W4249118233","https://openalex.org/W4366271744","https://openalex.org/W2408041648","https://openalex.org/W4292963246","https://openalex.org/W638890288","https://openalex.org/W564758893"],"abstract_inverted_index":{"1:Normal":[0],"and":[1,19,51,62,94,108,123,156,197,213,231,282,292,303,345,386,429,440,482,501,551,563,697],"pathological":[2],"anxiety.-":[3,20,25,31,541,662],"1":[4,67,136,193,278,351,421,522,542],"What":[5],"is":[6],"anxiety?.-":[7],"1.1":[8],"Anxiety":[9,13,38,473],"in":[10,14,405,514,652],"children.-":[11],"1.2":[12],"the":[15,387,650,653],"elderly.-":[16],"1.3":[17],"Personality":[18],"1.4":[21],"Cognitive":[22,372,444,477],"aspects":[23],"of":[24,30,34,42,60,71,128,143,243,254,272,392,397,451,464,516,540,649,661],"1.4.1":[26],"Gray":[27],"neurophysiological":[28],"model":[29],"1.5":[32],"Comorbidity":[33],"anxiety":[35,46,61,72,76,134,638,676],"disorders.-":[36,47,73,90,521],"1.6":[37],"scales.-":[39,259,265,341,415],"2":[40,69,138,195,280,353,423,524,544],"Relevance":[41],"laboratory":[43],"research":[44,512],"on":[45,311],"3":[48,91,140,219,288,362,425,526,571],"Genetic":[49],"factors":[50],"brain":[52,441],"imaging.-":[53,299,368],"4":[54,131,145,234,314,374,427,528,655],"Management.-":[55],"5":[56,152,252,334,408,443,536,681],"Discussion.-":[57,132,190,275,348,417,519,537,695],"2:Biological":[58],"basis":[59],"strategies":[63],"for":[64,182,186,250,332,336,410],"pharmacological":[65],"innovation.-":[66],"Introduction.-":[68,137,194,279,352,422,523,543],"Neurobiology":[70,439],"2.1":[74,199,284,355,548],"Generalised":[75,637,675],"disorder.-":[77,80,87,135,277,350,420,620,639,642,646,677,680],"2.2":[78,201,286,357,555],"Panic":[79,619,679],"2.3":[81,204,359,559],"Social":[82,608],"phobia.-":[83,192,218],"2.4":[84,206,566],"Post-traumatic":[85],"stress":[86,419,645],"2.5":[88,208],"Obsessive-compulsive":[89,641],"Recent":[92],"development":[93],"future":[95],"anxiolytics.-":[96,687],"3.1":[97,221,290,364,575],"5-HT":[98,388,556,689],"receptors.-":[99,102,110,116,125,389,690,693],"3.2":[100,223,297,366,618],"GABA":[101],"3.3":[103,225,300,369,636],"Neuropeptide":[104],"(CCK,":[105],"CRF,":[106],"NPY":[107],"NK)":[109],"3.4":[111,227,307,371,640],"Glutamatergic":[112],"pathways.-":[113],"3.5":[114,229,309,643],"Opioid":[115],"3.6":[117,647],"Neurosteroids.-":[118],"3.7":[119],"Equilibrium":[120],"between":[121],"GABA-benzodiazepine":[122],"other":[124],"3.8":[126],"Use":[127],"mutant":[129],"mice.-":[130],"3:Generalised":[133],"Diagnostic.-":[139,354],"The":[141,456,584,626,664],"phenomenon":[142],"worry.-":[144],"Neurobiology.-":[146,365],"4.1":[147,236,316,376,435,530,658],"Imaging":[148],"studies.-":[149],"4.2":[150,238,318,379,438,532,674],"Genetics.-":[151,370,527],"Physiopathology.-":[153,363],"6":[154,274,347,416,462,694],"Epidemiology":[155],"natural":[157],"course.-":[158],"7":[159,518],"Treatment.-":[160,375,529],"7.1":[161],"Psychological.-":[162,237,317,531],"7.2":[163],"Biofeedback.-":[164,486,533],"7.3":[165],"Pharmacological.-":[166,239,319,535],"7.3.1":[167],"Benzodiazepines.-":[168,321],"7.3.2":[169],"Buspirone.-":[170,506],"7.3.3":[171],"Venlafaxine.-":[172],"7.3.4":[173],"SSRIs.-":[174,326],"7.3.5":[175],"Tricyclics.-":[176,491],"7.3.6":[177],"Other":[178,328,508,632],"drugs.-":[179,509],"7.3.7":[180],"Algorithm":[181,249,331],"treatment.-":[183,251,333,378,381],"8":[184],"Methodology":[185,253,335,409],"clinical":[187,255,337,411],"investigation.-":[188,338,412],"9":[189],"4:Social":[191],"Diagnosis":[196,281],"comorbidity.-":[198],"Subtypes.-":[200],"Differential":[202],"diagnosis.-":[203],"Comorbidity.-":[205,285,356,426],"Epidemiology.-":[207,287,358,424,525],"Natural":[209,360],"history.-":[210,361],"2.6":[211],"Childhood":[212],"adolescence":[214],"versus":[215,245],"adult":[216],"social":[217],"Pathophysiology.-":[220,289],"Genetic.-":[222,308],"Neurophysiology.-":[224],"Neuroimaging.-":[226],"Environment.-":[228],"Gender":[230],"cultural":[232,403],"differences.-":[233],"Treatments.-":[235,315],"4.3":[240,534,678],"Comparison,":[241],"combination":[242],"drug":[244],"cognitive-behavioral":[246],"therapy.-":[247,398,471,478],"4.4":[248],"investigations.-":[256],"5.1":[257,339,413,449,688],"Rating":[258],"5.2":[260,342,453,691],"Self-assessment":[261],"questionnaires.-":[262],"5.3":[263,460],"Clinician/computer-administered":[264],"5.4":[266],"Health":[267],"Outcome":[268],"Assessments.-":[269],"5.5":[270],"Assessment":[271,450],"recovery.-":[273],"5:Panic":[276],"aetiology.-":[283],"Autonomic":[291],"central":[293],"nervous":[294],"system":[295],"dysfunctions.-":[296,373],"Brain":[298,367],"Respiratory":[301],"function":[302],"carbon":[304],"dioxide":[305],"sensitivity.-":[306],"Impact":[310],"cognitive":[312],"processes.-":[313],"4.2.1":[320,382],"4.2.2":[322,384],"Tricyclic":[323],"antidepressants.-":[324],"4.2.3":[325,390],"4.2.4":[327,395],"treatments.-":[329],"4.2.5":[330,399],"Psychometric":[340,414],"Assessing":[343],"response":[344],"remission.-":[346],"6:Obsessive-compulsive":[349],"Psychological":[377],"Pharmacological":[380,488],"Clomipramine.-":[383],"SSRI":[385],"Addition":[391],"atypical":[393],"neuroleptics.-":[394],"Course":[396],"Children.-":[400],"4.2.6":[401],"Some":[402,659],"differences":[404],"treatment":[406],"practice.-":[407],"7:Posttraumatic":[418],"Physiological":[428,436],"neurological":[430],"abnormalities":[431],"associated":[432,446],"with":[433,447],"PTSD.-":[434,448,452,465,517],"abnormalities.-":[437,442],"dysfunction":[445],"Attentional":[454],"bias:":[455],"emotional":[457],"Stroop":[458,666],"test.-":[459,586,597,602,606,669],"Memory.-":[461],"Treatment":[463],"6.1":[466],"Psychotherapeutic":[467],"approach.-":[468,489],"6.1.1":[469],"Exposure":[470],"6.1.2":[472],"management":[474],"programs.-":[475],"6.1.3":[476],"6.1.4":[479],"Eye":[480],"movement":[481],"desensitisation":[483],"reprocessing.-":[484],"6.2":[485],"6.3":[487],"6.3.1":[490],"6.3.2":[492],"Selective":[493],"serotonin":[494],"reuptake":[495],"inhibitors.-":[496],"6.3.3":[497],"Anticonvulsants.-":[498],"6.3.4":[499],"?-blocker":[500],"a2-agonist.-":[502],"6.3.5":[503],"?l-antagonists.-":[504],"6.3.6":[505],"6.3.7":[507],"6.3.8":[510],"New":[511],"strategy":[513],"pharmacotherapy":[515],"8:Phobic":[520],"9:Laboratory":[538],"models":[539,660],"Biological":[545],"animal":[546,573],"models.-":[547,574,635,654,657],"GABAergic":[549],"transmission":[550],"benzodiazepine":[552],"receptor":[553,557],"function.-":[554],"knockouts.-":[558,565],"Corticotropin-releasing":[560],"hormone":[561],"mutation":[562],"CRH-receptor":[564],"Genetically":[567],"selected":[568],"alcohol-preferring":[569],"rats.-":[570],"Behavioural":[572],"Anxiety.-":[576],"3.1.1":[577],"Elevated":[578,581],"plus-maze.-":[579],"3.1.2":[580],"T-maze.-":[582],"3.1.3":[583],"holeboard":[585],"3.1.4":[587],"Stress-induced":[588],"hyperthermia.-":[589],"3.1.5":[590],"Fear":[591,671],"potentiated":[592,672],"startle.-":[593,673],"3.1.6":[594],"Burying":[595],"behaviour":[596],"3.1.7":[598],"Stretched":[599],"attend":[600],"posture":[601],"3.1.8":[603],"Light-dark":[604],"transition":[605],"3.1.9":[607],"interaction.-":[609],"3.1.10":[610],"Ultrasonic":[611],"distress":[612],"vocalisation.-":[613],"3.1.11":[614],"A":[615],"primate":[616],"model.-":[617,624],"3.2.1":[621],"Periaqueductal":[622],"gray":[623],"3.2.2":[625],"mouse":[627],"defence":[628],"test":[629],"battery.-":[630],"3.2.3":[631],"new":[633],"behavioural":[634],"Posttraumatic":[644],"Effects":[648],"antidepressants":[651],"Human":[656],"4.1.1":[663],"video-recorded":[665],"colour":[667],"word":[668],"4.1.2":[670],"Issues":[682],"relevant":[683],"to":[684],"some":[685],"non-benzodiazepine":[686],"Cholecystokinin":[692],"10:Discussion":[696],"perspectives.-":[698],"Future":[699],"perspectives.":[700]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W583234580","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
